Project Number 5R21AG031969-02 Agency/Funding Organization NIA Funding Year 2009 View Full Project Details for PRECLINICAL TESTING OF AN O-GLCNACASE INHIBITOR TO BLOCK NEURODEGENERATION FOR AD Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator VOCADLO, DAVID J Principal Investigator First Name DAVID J Principal Investigator Last Name VOCADLO Awardee Organization Simon Fraser University Awardee State BC Contact PI Country Canada Project Detail Funding Opportunity Announcement PAS-06-261: Grants for Alzheimer's Disease Drug Discovery (R21) FY Overall Cost $124,729 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official BUCKHOLTZ, NEIL Related Resources Repository [AlzPED] Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice.
